A molecular dynamics study of conformations of beta-cyclodextrin and its eight derivatives in four different solvents

Understanding the atomic level interactions and the resulting structural characteristics is required for developing beta-cyclodextrin ($\beta$CD) derivatives for pharmaceutical and other applications. The effect of four different solvents on the structures of the native $\beta$CD and its hydrophilic (methylated $\beta$CD; ME$\beta$CD and hydroxypropyl $\beta$CD; HP$\beta$CD) and hydrophobic derivatives (ethylated $\beta$CD; ET$\beta$CD) were explored using molecular dynamics (MD) simulations and solvation free energy calculations. The native $\beta$CD, 2-ME$\beta$CD, 6-ME$\beta$CD, 2,6-DM$\beta$CD, 2,3,6-TM$\beta$CD, 6-HP$\beta$CD, 2,6-HP$\beta$CD and 2,6-ET$\beta$CD in non-polar solvents (cyclohexane; CHX and octane; OCT) were stably formed in symmetric cyclic cavity shape through their intramolecular hydrogen bonds. In contrast, $\beta$CDs in polar solvents (methanol; MeOH and water; WAT) exhibited large structural changes and fluctuations leading to significant deformations of their cavities. Hydrogen bonding with polar solvents was found to be one of the major contributors to this behavior: solvent-\b{eta}CD hydrogen bonding strongly competes with intramolecular bonding leading to significant changes in structural stability of $\beta$CDs. The exception to this is the hydrophobic 2,6-ET$\beta$CD which retained its spherical cavity in all solvents. Based on this, it is proposed that 2,6-ET$\beta$CD can act as a sustained release drug carrier.